2nd Quarter - Report — PRIME THERAPEUTICS for PRIME THERAPEUTICS (2009)

Firm

PRIME THERAPEUTICS

Client

PRIME THERAPEUTICS

Income

—

Expenses

$106,702

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1204 "Community Pharmacy Fairness Act" HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D

Lobbyist	Covered position, as disclosed
JERRY STEFFL	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); White House Office

Bills named: H.R. 1204 (111th), H.R. 1427 (111th), H.R. 1548 (111th)

Insurance INS

HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D

Lobbyist	Covered position, as disclosed
JERRY STEFFL	—

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); White House Office

Bills named: H.R. 1548 (111th), H.R. 1427 (111th), H.R. 1204 (111th)

Pharmacy PHA

HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D

Lobbyist	Covered position, as disclosed
JERRY STEFFL	—

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; White House Office

Bills named: H.R. 1204 (111th), H.R. 1427 (111th), H.R. 1548 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.